(Q47174502)

English

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type

scientific article published on 31 August 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

1 reference

based on heuristic

inferred from title

chronic idiopathic myelofibrosis

1 reference

based on heuristic

inferred from title

author name string

A Bacigalupo

1

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

M Soraru

2

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

A Dominietto

3

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

S Pozzi

4

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

S Geroldi

5

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

M T Van Lint

6

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

A Ibatici

7

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

A M Raiola

8

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

F Frassoni

9

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

F De Stefano

10

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

S Verdiani

11

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

L Casarino

12

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

G Barosi

13

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

language of work or name

0 references

publication date

31 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

45

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

3

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

458-463

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

21 January 2018

Myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell transplantation for myelofibrosis: a report from two Canadian centers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of allogeneic stem cell transplantation in patients with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.188

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2009.188

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/19718055

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47174502&oldid=2208449340"